1. Show article details.

    12 Industrials Stocks Moving In Monday's After-Market Session

    Benzinga – 5:33 PM ET 08/08/2022

      This article was generated by Benzinga's automated content engine and reviewed by an editor.

  2. Show article details.

    BWX Technologies: Q2 Earnings Insights

    Benzinga – 5:06 PM ET 08/08/2022

      BWX Technologies reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. BWX Technologies beat estimated earnings by 9.33%, reporting an EPS of $0.82 versus an estimate of $0.75. Revenue was up $48.90 million from the same period last year.

  3. Show article details.

    BWX Technologies Reports Robust Second Quarter 2022 Results; Increases 2022 Revenue and Adjusted EBITDA(1) Guidance

    Business Wire – 4:10 PM ET 08/08/2022

    LYNCHBURG, Va.---- BWX Technologies, Inc. (BWXT) reported second quarter 2022 revenue of $554 million, a 10% increase compared with $505 million in the second quarter 2021. “BWXT delivered a strong second quarter despite a few operational challenges," said Rex D. Geveden, president and chief executive officer.

  4. Show article details.

    Earnings Scheduled For August 8, 2022

    Benzinga – 5:30 AM ET 08/08/2022

      ** Pyxis Tankers is likely to report earnings for its second quarter. ** Kandi Technologies Gr is projected to report earnings for its second quarter. ** Tredegar is estimated to report earnings for its second quarter. ** PowerFleet is likely to report quarterly loss at $0.12 per share on revenue of $34.36 million. ** PDS Biotechnology is projected to report earnings for its second quarter.

  5. Show article details.

    BRIEF-BWXT Names Sharon H. Smoot As President Of Nuclear Operations Group

    Reuters – 8:13 AM ET 07/27/2022

    BWX Technologies Inc (BWXT): * BWXT NAMES SHARON H. SMOOT AS PRESIDENT OF NUCLEAR OPERATIONS GROUP Source text for Eikon: Further company coverage:

  6. Show article details.

    BWXT Names Sharon H. Smoot as President of Nuclear Operations Group

    Business Wire – 6:45 AM ET 07/27/2022

    BWX Technologies, Inc. (BWXT) has appointed Sharon H. Smoot as president of BWXT’s Nuclear Operations Group, Inc.. In this role, she will have full responsibility for NOG’s mission to provide a complete range of nuclear components and services, including the manufacture of nuclear reactor components for U.S. Navy submarines and aircraft carriers and other nuclear and non-nuclear R&D and component prod...

  7. Show article details.

    BWX Technologies to Announce Second Quarter 2022 Results on Monday, August 8

    Business Wire – 8:00 AM ET 07/14/2022

    BWX Technologies, Inc. (BWXT) will issue a press release detailing second quarter 2022 results on Monday, August 8, 2022, after market close and will host a conference call at 5:00 p.m. EDT. Listen-only participants are encouraged to participate and view the supporting presentation via the Internet at www.bwxt.com/investors.

  8. Show article details.

    BWXT Canada Secures C$130M Component Manufacturing Contract

    Benzinga – 12:11 PM ET 07/05/2022

    BWXT Canada Secures C$130M Component Manufacturing Contract

  9. Show article details.

    BRIEF-BWX Tech Canada Awarded C$130 Mln Component Manufacturing Contract From Bruce Power

    Reuters – 7:32 AM ET 07/05/2022

    BWX Technologies Inc (BWXT): * BWX TECHNOLOGIES CANADA AWARDED C$130 MILLION COMPONENT MANUFACTURING CONTRACT FROM BRUCE POWER. * BWX Technologies Inc (BWXT) - FEEDERS WILL BE MANUFACTURED BY MEMBERS OF UNITED STEELWORKERS LOCAL 2859 AT BWXT CANADA'S CAMBRIDGE, ONTARIO FACILITY. * BWX Technologies Inc (BWXT) - CONTRACT WAS BOOKED IN Q1 OF 2022, AND PRE-PRODUCTION QUALIFICATION WORK FOR PROJECT IS CURRENTLY UNDERWAY.

  10. Show article details.

    BWXT Canada Awarded CA$130 Million Component Manufacturing Contract from Bruce Power

    Business Wire – 6:45 AM ET 07/05/2022

    BWX Technologies, Inc. (BWXT) today announced a contract awarded by Bruce Power valued at approximately CA$130 million in support of Bruce Power’s Major Component Replacement Project. The contract is for the fabrication and supply of replacement feeders for Bruce Power’s reactor units 3, 4, 5, 7 and 8 and represents an integral part of Bruce Power’s MCR Project.

  11. Show article details.

    BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products

    Benzinga – 10:20 AM ET 06/27/2022

    BWXT Medical, Bayer Ink Commercial Agreement For Actinium-225 Based Products

  12. Show article details.

    BRIEF-Bwxt Medical Executes Commercial Agreement With Bayer For Supply Of Actinium-225 Based Products

    Reuters – 6:50 AM ET 06/27/2022

    BWX Technologies Inc (BWXT): * BWXT MEDICAL EXECUTES COMMERCIAL AGREEMENT WITH BAYER FOR SUPPLY OF ACTINIUM-225 BASED PRODUCTS. * BWX Technologies Inc (BWXT) - PARTIES EXPECT SUPPLY TO COMMENCE LATER THIS YEAR. * BWX Technologies Inc (BWXT) - UNDER TERMS OF COMMERCIAL AGREEMENT, BAYER WILL PURCHASE HIGH-PURITY AC-225 FROM BWXT MEDICAL AT PRE-DETERMINED PRICES Source text for Eikon: Further company coverage:

  13. Show article details.

    BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products

    Business Wire – 6:45 AM ET 06/27/2022

    BWX Technologies, Inc. (BWXT) announced today that subsidiary BWXT Medical Ltd. has executed a commercial agreement with Bayer AG to supply high-purity Actinium-225. Today’s announcement follows the agreement reached by the two companies in September 2021. Ac-225 is a highly powerful radioisotope used in targeted alpha therapies.

  14. Show article details.

    BWXT Medical, TRIUMF Agree To Manufacture High Purity Ac-225 Based Products

    Benzinga – 12:04 PM ET 06/13/2022

    BWXT Medical, TRIUMF Agree To Manufacture High Purity Ac-225 Based Products

  15. Show article details.

    BRIEF-BWXT Medical, Triumf Execute Agreement For Manufacture Of High Purity Ac-225 Based Products

    Reuters – 7:14 AM ET 06/13/2022

    BWX Technologies Inc (BWXT): * BWXT MEDICAL AND TRIUMF EXECUTE AGREEMENT FOR MANUFACTURE OF HIGH PURITY AC-225 BASED PRODUCTS Source text for Eikon: Further company coverage:

  16. Show article details.

    BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products

    Business Wire – 6:45 AM ET 06/13/2022

    BWX Technologies, Inc. (BWXT) announced today that subsidiary BWXT Medical Ltd. and TRIUMF, Canada’s particle accelerator centre, have executed a licensing and services agreement that strengthens their existing partnership for the production of medical isotopes.

  17. Show article details.

    BWX Technologies Secures Contract To Build Nuclear Microreactor In US

    Benzinga – 2:00 PM ET 06/09/2022

    BWX Technologies Secures Contract To Build Nuclear Microreactor In US

  18. Show article details.

    BRIEF-BWX Technologies To Build First Advanced Nuclear Microreactor In United States

    Reuters – 6:59 AM ET 06/09/2022

    BWX Technologies Inc (BWXT): * BWX TECHNOLOGIES (BWXT) - WILL BUILD FIRST ADVANCED NUCLEAR MICROREACTOR IN UNITED STATES UNDER A CONTRACT AWARDED BY U.S. DOD STRATEGIC CAPABILITIES OFFICE. * BWX - PROJECT PELE FULL-SCALE TRANSPORTABLE MICROREACTOR PROTOTYPE WILL BE COMPLETED, DELIVERED IN 2024 FOR TESTING AT IDAHO NATIONAL LABORATORY.

  19. Show article details.

    BWXT to Build First Advanced Microreactor in United States

    Business Wire – 6:45 AM ET 06/09/2022

    U.S. Department of Defense Strategic Capabilities Office Selects BWXT to Manufacture and Deliver Project Pele Prototype Reactor to Idaho National Laboratory in 2024 BWX Technologies, Inc. (BWXT) will build the first advanced nuclear microreactor in the United States under a contract awarded by the U.S. Department of Defense Strategic Capabilities Office. This press release features multimedia.

  20. Show article details.

    BWX Technologies's Return On Capital Employed Insights

    Benzinga – 11:41 AM ET 06/03/2022

    Pulled from Benzinga Pro data, BWX Technologies posted Q1 earnings of $59.07 million, an increase from Q4 of 49.47%. Sales dropped to $531.00 million, a 10.3% decrease between quarters. Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business.

Page:

Today's and Upcoming Events

  • Oct
    31

    BWXT to announce Q3 earnings (Unconfirmed)

  • Aug
    18

    BWXT ex-Dividend for $0.22 on 08/18/2022

    • Announce Date: 08/08/2022
    • Record Date: 08/19/2022
    • Pay Date: 09/08/2022

Past Events (last 90 days)

  • Aug
    08

    BWXT announced Q2 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.